In 2025, the Beta-Glucanase market was valued at USD 438.1 million. Based on Future Market Insights' analysis, demand for Beta-Glucanase is estimated to grow to USD 495.0 million in 2026 and USD 912.0 million by 2036. FMI projects a CAGR of 6.3% during the forecast period.
The absolute dollar expansion from 2026 to 2036 amounts to approximately USD 417.0 million, reflecting strong demand pull from dietary supplement manufacturers and functional food formulators seeking evidence-backed immune and cardiovascular health ingredients. Growth is moderated by the premium cost of certified and standardized Beta-Glucanase preparations relative to competing immunomodulatory ingredients, and by the complexity of clinical substantiation required for certain health claim pathways under FDA and EFSA regulatory frameworks.
As per FMI, growing consumer awareness of immune health and cardiovascular risk management, combined with regulatory-approved health claims for beta-glucan-containing products in key markets, creates a durable demand foundation for Beta-Glucanase across functional food and nutraceutical manufacturing supply chains. China leads country-level growth at 8.5% CAGR, driven by domestic nutraceutical market expansion, active government investment in enzyme biotechnology research, and Angel Yeast's commercial-scale production of yeast-derived Beta-Glucanase for export and domestic food applications. India follows at 7.9%, with demand anchored in Ayurveda-adjacent functional supplement formulation and growing institutional procurement from pharmaceutical-grade supplement manufacturers.
Germany records 7.2% CAGR under EFSA-approved health claim frameworks for beta-glucan and oat-fiber cholesterol reduction positioning, supporting premium ingredient procurement by bakery and supplement manufacturers. France advances at 6.6%, driven by fortified dairy and functional beverage formulation activity. The United Kingdom grows at 6.0%, with oat-based soluble Beta-Glucanase commanding sustained demand in heart-health product lines across pharmacy and health food retail. The United States expands at 5.4%, anchored by Cargill, Alltech, and Garuda International supplying standardized yeast Beta-Glucanase to dietary supplement contract manufacturers. Brazil posts 4.7%, with early-stage functional food adoption and animal feed inclusion as the primary growth driver. For detailed regional intelligence, refer to FMI's Beta-Glucanase Market report.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 495.0 million |
| Industry Value (2036) | USD 912.0 million |
| CAGR (2026 to 2036) | 6.3% |
Beta-Glucanase is a polysaccharide compound derived primarily from yeast cell walls, cereal grains (barley and oats), and fungal sources (mushrooms), available in soluble and insoluble functional forms. It is commercially supplied as a bioactive ingredient for immune modulation, cholesterol management, digestive health support, and texture enhancement across dietary supplements, food, beverage, and animal feed applications.
The report covers global and regional market sizes for Beta-Glucanase across all commercial source types, functional forms, and application segments, forecast data from 2026 to 2036, and country-level CAGR analysis across more than 40 countries.
The scope excludes beta-glucanase enzymes used solely in industrial bioprocessing contexts unrelated to food or health applications, synthetic immune modulators, and finished consumer products in which Beta-Glucanase appears as a listed but non-primary active ingredient below functional threshold levels.
The beta-glucanase market is demonstrating steady growth, supported by the rising demand for functional ingredients in food, beverage, feed, and nutraceutical industries. Increasing awareness of digestive health and immunity-boosting products is driving the integration of beta-glucanase into dietary supplements and wellness products. The enzyme’s ability to break down complex beta-glucans into simpler, bioavailable components is being leveraged to improve nutrient absorption and functional efficacy across a wide range of applications.
Growing investments in enzyme biotechnology, along with advancements in fermentation processes, are enhancing product efficiency, stability, and cost-effectiveness. The market is also benefiting from the expansion of clean-label and natural product categories, where beta-glucanase is being increasingly adopted as a natural processing aid.
Regulatory support for safe and effective enzyme-based ingredients in human and animal nutrition is further accelerating adoption As consumer preferences shift toward health-oriented food products and sustainable feed solutions, the market is anticipated to expand significantly, supported by innovation in enzyme formulations and broader acceptance of enzyme-based functional solutions across global markets.
The beta-glucanase market is segmented by source, functionality, application, and geographic regions. By source, beta-glucanase market is divided into Yeast, Cereal (Barley, Oats), and Others (Mushrooms). In terms of functionality, beta-glucanase market is classified into Soluble Beta-Glucanase and Insoluble Beta-Glucanase. Based on application, beta-glucanase market is segmented into Health & Dietary Supplements, Bakery Products, Foods & Beverages, Cosmetics & Personal Care, Dairy & Frozen Products, and Others (Animal Feed). Regionally, the beta-glucanase industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The yeast source segment is projected to account for 47.3% of the beta-glucanase market revenue share in 2025, making it the leading source category. This dominance is being attributed to the abundance of yeast-derived beta-glucans in various applications and the cost-effective production methods associated with yeast fermentation. The enzymatic extraction from yeast provides high yield and consistency, which supports large-scale commercial use in both food and feed industries.
The stability and effectiveness of yeast-derived beta-glucanase have been demonstrated across a wide range of processing environments, making it suitable for industrial applications that require reliable enzyme activity under varying conditions. The demand for yeast-based solutions is also being reinforced by their acceptance in natural and clean-label formulations, aligning with growing consumer interest in sustainable and traceable sources.
Advances in fermentation technologies and strain development are enabling higher enzyme purity and activity, ensuring consistent performance across applications As industries prioritize efficiency and sustainability, yeast remains the most practical and scalable source of beta-glucanase, solidifying its leadership position in the global market.
The soluble beta-glucanase functionality segment is expected to hold 61.8% of the beta-glucanase market revenue share in 2025, establishing it as the leading functionality type. Its growth is being driven by the superior solubility and ease of incorporation into liquid and powdered formulations, making it highly suitable for nutraceuticals, beverages, and functional foods. Soluble beta-glucanase enhances bioavailability and efficacy, supporting its adoption in products targeted toward improving digestion and immune function.
The ability of soluble forms to retain stability across a range of processing conditions is further increasing their application potential in health and dietary supplements. Manufacturers are prioritizing soluble formulations due to their ability to blend seamlessly with other ingredients without compromising texture or taste, which is critical in consumer-facing products.
The segment’s expansion is also linked to ongoing research in biotechnology aimed at optimizing solubility and enzymatic activity With the growing trend toward functional and fortified food solutions, soluble beta-glucanase is expected to remain the preferred choice for manufacturers, ensuring its strong contribution to overall market growth.
The health and dietary supplements application segment is anticipated to capture 29.3% of the beta-glucanase market revenue share in 2025, making it the dominant application. The leadership of this segment is being fueled by the increasing consumer focus on digestive wellness, immunity enhancement, and preventive healthcare. Beta-glucanase is being incorporated into dietary supplements to improve the breakdown of beta-glucans, thereby enhancing nutrient absorption and overall effectiveness of formulations.
Its role in supporting gut health and immunity is particularly relevant as consumers prioritize natural solutions to strengthen resilience against lifestyle-related disorders and infections. The expanding nutraceutical sector, combined with rising disposable incomes and health-conscious lifestyles, is reinforcing demand for enzyme-based supplements. Regulatory acceptance of beta-glucanase as a safe and beneficial dietary ingredient is further driving adoption in supplement formulations.
The ability to combine beta-glucanase with other functional ingredients in capsules, powders, and liquid supplements is increasing product diversity and accessibility As the global demand for wellness products accelerates, the health and dietary supplements segment is expected to remain the largest contributor to market revenues.
A novel substance called beta-glucanase is currently being introduced to the market. It is a nutritional supplement produced from yeast cell walls. According to some research, beta-glucanase is good for the heart and can lower the chance of developing heart disease. Clinical testing of the product has shown that it effectively lowers levels of harmful cholesterol.
Future Market Insights analysis of the Beta-Glucanase market shows that demand is structured around specific procurement requirements across industrial, retail, and regulated product categories. FMI analysts observe that growth performance varies across application and regional segments, with premium and specialty demand tiers delivering above-average revenue per unit relative to standard commodity-grade supply.
FMI is of the opinion that the structural dynamic in this market reflects the interplay between production cost constraints and downstream buyer quality certification requirements. Suppliers able to demonstrate supply chain traceability, batch consistency, and regulatory compliance are positioned to secure disproportionate share of the premium procurement tier across all major geographic markets.
.webp "Top Country Growth Comparison Beta Glucanase Market Cagr (2026 2036)")
| Country | CAGR |
|---|---|
| China | 8.5% |
| India | 7.9% |
| Germany | 7.2% |
| France | 6.6% |
| UK | 6.0% |
| USA | 5.4% |
| Brazil | 4.7% |
The Beta-Glucanase Market is expected to register a CAGR of 6.3% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 8.5%, followed by India at 7.9%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.7%, yet still underscores a broadly positive trajectory for the global Beta-Glucanase Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 7.2%. The USA Beta-Glucanase Market is estimated to be valued at USD 174.1 million in 2025 and is anticipated to reach a valuation of USD 293.3 million by 2035. Sales are projected to rise at a CAGR of 5.4% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 22.5 million and USD 16.2 million respectively in 2025.
| Metric | Value |
|---|---|
| Quantitative Units | USD 495.0 million to USD 912.0 million, at a CAGR of 6.3% |
| Market Definition | Beta-Glucanase is a polysaccharide compound derived primarily from yeast cell walls, cereal grains (barley and oats), and fungal sources (mushrooms), available in soluble and insoluble functional forms. It is commercially supplied as a bioactive ingredient for immune modulation, cholesterol management, digestive health support, and texture enhancement across dietary supplements, food, beverage, and animal feed applications. |
| Source Segmentation | Yeast, Cereal (Barley and Oats), Others (Mushrooms) |
| Functionality Segmentation | Soluble Beta-Glucanase, Insoluble Beta-Glucanase |
| Application Segmentation | Health and Dietary Supplements, Bakery Products, Foods and Beverages, Cosmetics and Personal Care, Dairy and Frozen Products, Others (Animal Feed) |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa, and 40 plus countries |
| Forecast Period | 2026 to 2036 |
| Key Companies Profiled | Cargill Inc. (USA), Kerry Group Plc (Ireland), AIT Ingredients (France), Ohly GmbH (Germany), Biorigin Zilor (Brazil), Alltech Life Sciences (USA), Tate and Lyle Plc (UK), Koninklijke DSM N.V. (Netherlands), Garuda International Inc. (USA), Angel Yeast Co. Ltd. (China), Biotec BetaGlucans AS (Norway), Ceapro Inc. (Canada) |
| Approach | Hybrid bottom-up and top-down forecasting model, cross-validated against primary interview findings and public benchmark data |
How large is the demand for Beta-Glucanase in the global market in 2026?
Demand for Beta-Glucanase in the global market is estimated to be valued at USD 495.0 million in 2026.
What will the market size of the Beta-Glucanase market be by 2036?
The Beta-Glucanase market is projected to reach USD 912.0 million by 2036.
What is the expected CAGR for the Beta-Glucanase market between 2026 and 2036?
Demand for Beta-Glucanase is expected to grow at a CAGR of 6.3% between 2026 and 2036.
Which source segment holds the largest share in the Beta-Glucanase market in 2026?
Yeast source accounts for approximately 47.3% share in 2026, reflecting its established commercial production scale, consistent purity profiles, and broad acceptance in dietary supplement and functional food formulation applications.
Which functionality segment leads the Beta-Glucanase market in 2026?
Soluble Beta-Glucanase holds approximately 61.8% functionality share in 2026, supported by its superior bioavailability, proven cardiovascular and immune health mechanisms, and compatibility with beverage, supplement, and bakery product formulation requirements.
What is driving demand for Beta-Glucanase in China?
Domestic nutraceutical market expansion, government research investment in enzyme biotechnology, and commercial-scale yeast-derived Beta-Glucanase production by Angel Yeast Co. Ltd. drive China to the highest country-level growth rate of 8.5% CAGR among all covered markets.
What regulatory frameworks support Beta-Glucanase demand in Germany?
German food and supplement manufacturers operate under EFSA-approved qualified health claims recognizing that beta-glucan from oats and barley contributes to normal blood cholesterol maintenance, creating a defined minimum daily dose specification that drives standardized ingredient procurement from certified European suppliers.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Beta-Glucanase Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
